Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 1
This trial is looking at the safety of CD19 T cells as a treatment for people with diffuse large B cell lymphoma before a donor stem cell transplant.
Recruitment start: 15 June 2016
Recruitment end: 4 December 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Karl Peggs
University College London (UCL)
Bloodwise
Cancer Research UK & UCL Cancer Trials Centre (UCL CTC)
NIHR Clinical Research Network: Cancer
Last reviewed: 30 April 2020
CRUK internal database number: 12681
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
